Vacci-nation: A case study in health and prosperity

Article

Vaccines have been integral to health and prosperity in the last three centuries.

The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.

Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.

On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.

Related items

  1. A mother and child from behind looking out of a window

    Restoring security: Understanding the effects of removing the two-child limit across the UK

    The government’s decision to lift the two-child limit marks one of the most significant changes to the social security system in a decade.
  2. A group of healthcare professionals sitting in a staff common room in a hospital in Newcastle

    Building a healthier, wealthier Britain: Launching the IPPR Centre for Health and Prosperity

    Following the success of our Commission on Health and Prosperity, IPPR is excited to launch the Centre for Health and Prosperity.
  3. The Home Office building in London

    A ‘paradigm shift’ in asylum and immigration policy?

    In 2019, a package of asylum reforms known as the ‘paradigm shift’ was passed by a broad party consensus in the Danish parliament.